Insiders · Profile

Murphy Polly A.

Director at Atea Pharmaceuticals · Director at Celcuity. Filing since 20 Dec 2021. CIK 0001829248

AVIR Atea Pharmaceuticals, Inc. Director · 2 trades CELC Celcuity Inc. Director · 1 trade

Company

Date

Role

Action

Shares

Amount

Of holding

AVIR Atea Pharmaceuticals, Inc.

18 May 2025

Director

Bought

6,100

$25.45K

7.1%

CELC Celcuity Inc.

22 Nov 2022

Director

Bought

5,000

$48.38K

opened

AVIR Atea Pharmaceuticals, Inc.

20 Dec 2021

Director

Bought

12,000

$102.80K

106%

3 decisions on file.